← Leaderboards
Virendra Nath Pandey
Univ Of Med/Dent Of Nj-Nj Medical School
$4,697,445
Attributed
$4,697,445
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $665.2K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$4,697,445 · 7
By mechanism
R01$2,699,020 · 2
R21$1,998,425 · 5
Top collaborators
No co-investigators on record.
Most similar at Univ Of Med/Dent Of Nj-Nj Medical School
Same institution · by research overlap
- Leonard Gerald Meggs$842,692
- Neerja Kaushik-Basu$2,167,839
Others in their field
Top investigators on “Virus Replication”
- Constance Ann Benson · University Of California, San Diego$187,673,896
- Judith S. Currier · University Of California Los Angeles$137,892,773
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Barton F Haynes · Duke University$110,672,613
- Charles M. Rice · Rockefeller University$53,754,576
- Rama Rao Amara · Emory University$53,347,944
Research focus
Virus ReplicationSiteViralRetroviridaeAntiviral AgentsHuman Immunodeficiency Virus 1Drug DevelopmentStructureAffinityComplexCytotoxicityBinding (Molecular Function)Virus RnaDrug ResistanceCellsVirus DiseasesDesignAnti-Hiv AgentsIn VitroHiv-1Viral GenomeDrug Screening /EvaluationDrug SensitivityAffect
Grant awards (18)
Implication of RNase H domain on dimer stability and drug sensitivity of HIV-1 RT$238,500
R21 · FY2014 · AI · contact PI
Implication of RNase H domain on dimer stability and drug sensitivity of HIV-1 RT$186,825
R21 · FY2013 · AI · contact PI
FUSE Binding Protein As a Cellular Effector of HCV Replication$231,660
R21 · FY2011 · DK · contact PI
Structure-Based Development of nonnucleoside anti-HIV-1 RT Drugs$236,205
R21 · FY2010 · AI · contact PI
Proteomics of HCV Replication Complex$234,000
R21 · FY2010 · AI · contact PI
FUSE Binding Protein As a Cellular Effector of HCV Replication$195,000
R21 · FY2010 · DK · contact PI
Structure-Based Development of nonnucleoside anti-HIV-1 RT Drugs$209,110
R21 · FY2009 · AI · contact PI
Proteomics of HCV Replication Complex$195,000
R21 · FY2009 · AI · contact PI
Genome Targeted Inhibitors of Retroviruses$368,605
R01 · FY2007 · AI · contact PI
Genome Targeted Inhibitors of Retroviruses$379,614
R01 · FY2006 · AI · contact PI
Genome Targeted Inhibitors of Retroviruses$388,750
R01 · FY2005 · AI
Genome Targeted Inhibitors of Retroviruses$388,750
R01 · FY2004 · AI
Genome Targeted Inhibitors of Retroviruses$194,375
R01 · FY2003 · AI
Genome Targeted Inhibitors of Retroviruses$272,125
R21 · FY2002 · AI
STRUCTURE/FUNCTION RELATIONSHIP IN HIV1 RT$265,606
R01 · FY2001 · CA
GENOME TARGETED INHIBITORS OF RETROVIRUSES$231,089
R01 · FY2001 · AI
STRUCTURE/FUNCTION RELATIONSHIP IN HIV1 RT$257,871
R01 · FY2000 · CA
GENOME TARGETED INHIBITORS OF RETROVIRUSES$224,360
R01 · FY2000 · AI